Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Multiple Site, Randomized, Placebo-Controlled Trial of Oral Valproic Acid for Autosomal Dominant Retinitis Pigmentosa

NCT01233609 is registered in ClinicalTrials.gov with Foundation Fighting Blindness as lead sponsor.

NCT NCT01233609
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01233609 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Multiple Site, Randomized, Placebo-Controlled Trial of Oral Valproic Acid for Autosomal Dominant Retinitis Pigmentosa
Lead sponsor
Foundation Fighting Blindness
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2010
Completion date
December 31, 2015
Enrollment
90 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

retinitis pigmentosa